Recherche
-
Comparison of endothelial promoter efficiency and specificity in mice reveals a subset of Pdgfb-positive hematopoietic cells.
(Journal of Thrombosis and Haemostasis. vol. 17, n° 5, pp. 827-840, 2019-01-01)Article de revueLibre accès -
Vascular endothelial cell expression of JAK2V617F is sufficient to promote a pro-thrombotic state due to increased P-selectin expression
(Haematologica. vol. 104, n° 1, pp. 70–81, 2019-01)Article de revueLibre accès -
Pathogenesis of cardiovascular events in BCR-ABL1-negative myeloproliferative neoplasms.
(Leukemia. vol. 35, n° 4, pp. 935-955, 2021-01-01)Article de revue -
Absence of JAK2V617F Mutated Endothelial Colony-Forming Cells in Patients With JAK2V617F Myeloproliferative Neoplasms and Splanchnic Vein Thrombosis
(HemaSphere. vol. 4, n° 3, pp. e364, 2020-06)Article de revueLibre accès -
Role of red cell mass evaluation in myeloproliferative neoplasms with splanchnic vein thrombosis and normal hemoglobin value: a study of the France Intergroupe des Syndromes myeloprolifératifs.
(Haematologica, 2024-02-08)Article de revueLibre accès -
Assessment of circulating blood lymphocytes in adult patients on rituximab to treat immune thrombocytopenia: Circulating number of NK cells is associated with the response at 6 months.
(British Journal of Haematology, 2023-04-20)Article de revueLibre accès